RivoceranibVarious toxicities: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1712卷 / 1期

关键词：

D O I：

10.1007/s40278-018-49781-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：492 / 492

相关论文

共 50 条

[31] Camrelizumab/rivoceranibVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1811 (1) : 79 - 79
[32] Camrelizumab/rivoceranibVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1925 (1) : 145 - 145
[33] RivoceranibVarious toxicites: case report
Reactions Weekly, 2018, 1709 (1) : 228 - 228
[34] RivoceranibVarious toxcities: case report
Reactions Weekly, 2018, 1719 (1) : 207 - 207
[35] Gimeracil/oteracil/tegafur/rivoceranibVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1844 (1) : 197 - 197
[36] Pyrotinib/rivoceranibVarious toxicites: case report
Reactions Weekly, 2020, 1790 (1) : 199 - 199
[37] Camrelizumab/irinotecan/rivoceranibVarious toxicities and lack of efficacy: 6 case reports
Reactions Weekly, 2023, 1986 (1) : 119 - 119
[38] Docetaxel/gimeracil/oteracil/tegafur/rivoceranibVarious toxicities: 7 case reports
Reactions Weekly, 2019, 1758 (1) : 155 - 155
[39] Programmed-cell-death-1-receptor-antagonists/rivoceranibVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1833 (1) : 331 - 331
[40] Multiple drugsVarious toxicities: Case report: case report
Reactions Weekly, 2021, 1837 (1) : 499 - 499

← 1 2 3 4 5 →